Incremental cardiovascular costs and resource use associated with diabetes: An assessment of 29,863 patients in the US managed-care setting

Cardiovascular Diabetology

Volumn 8, Issue , 2009, Pages 53-

  Straka, Robert J ^a   Liu, Larry Z ^b   Girase, Prafulla S ^c   DeLorenzo, Allyson ^d   Chapman, Richard H ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b PFIZER INC   (United States)

^c IQVIA   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DATA BASE; FOLLOW UP; GENDER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MANAGED CARE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; RESOURCE ALLOCATION; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 70449512692     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-8-53     Document Type: Article

References (20)

1. American Diabetes Association Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008, 31(3):596-615. 10.2337/dc08-9017, 18308683.
2. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999, 100(10):1134-1146.
3. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16(2):434-444. 10.2337/diacare.16.2.434, 8432214.
4. Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339(4):229-234. 10.1056/NEJM199807233390404, 9673301.
5. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006, 332(7533):73-78. 10.1136/bmj.38678.389583.7C, 1326926, 16371403.
6. Wilson PW. Diabetes mellitus and coronary heart disease. Am J Kidney Dis 1998, 32(5 Suppl 3):S89-100. 10.1053/ajkd.1998.v32.pm9820468, 9820468.
7. Smith JW, Marcus FI, Serokman R. Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 1984, 54(7):718-721. 10.1016/S0002-9149(84)80196-4, 6385680.
8. Singer DE, Moulton AW, Nathan DM. Diabetic myocardial infarction. Interaction of diabetes with other preinfarction risk factors. Diabetes 1989, 38(3):350-357. 10.2337/diabetes.38.3.350, 2917699.
9. Cubbon RM, Wheatcroft SB, Grant PJ, Gale CP, Barth JH, Sapsford RJ, Ajjan R, Kearney MT, Hall AS. Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur Heart J 2007, 28(5):540-545. 10.1093/eurheartj/ehl510, 17289742.
10. Cubbon RM, Abbas A, Wheatcroft SB, Kilcullen N, Das R, Morrell C, Barth JH, Kearney MT, Hall AS. Diabetes mellitus and mortality after acute coronary syndrome as a first or recurrent cardiovascular event. PLoS ONE 2008, 3(10):e3483. 10.1371/journal.pone.0003483, 2567028, 18941531.
11. Expert Panel on Detection Evaluation And Treatment of High Blood Cholesterol In Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486-2497. 10.1001/jama.285.19.2486, 11368702.
12. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110(2):227-239. 10.1161/01.CIR.0000133317.49796.0E, 15249516.
13. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007, 115(1):114-126. 10.1161/CIRCULATIONAHA.106.179294, 17192512.
14. Glauber H, Brown J. Impact of cardiovascular disease on health care utilization in a defined diabetic population. J Clin Epidemiol 1994, 47(10):1133-1142. 10.1016/0895-4356(94)90100-7, 7722547.
15. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997, 20(9):1396-1402. 10.2337/diacare.20.9.1396, 9283786.
16. Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999, 159(16):1873-1880. 10.1001/archinte.159.16.1873, 10493317.
17. Brown JB, Nichols GA, Glauber HS, Bakst AW. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care 1999, 22(7):1116-1124. 10.2337/diacare.22.7.1116, 10388977.
18. Nichols GA, Brown JB. The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes. Diabetes Care 2002, 25(3):482-486. 10.2337/diacare.25.3.482, 11874934.
19. Caro JJ, Ward AJ, O'Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 2002, 25(3):476-481. 10.2337/diacare.25.3.476, 11874933.
20. O'Brien JA, Patrick AR, Caro J. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin Ther 2003, 25(3):1017-1038. 10.1016/S0149-2918(03)80122-4, 12852716.